In a few decades, gene-editing technologies could reduce the likelihood of common human diseases. Societies must use this ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...

A team of scientists claims that the risk of common conditions like heart disease could be slashed by editing people's ...

Anges Inc. has entered into a sponsored research agreement with Stanford University School of Medicine for the development of novel cancer therapies using genome editing technology. The parties aim to ...

Genome editing with CRISPR-Cas is often associated with the induction of mutations. However, a team of researchers from the ...

MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025NHP Proof-of-Concept Anticipated for Secreted Protein ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

We are excited to welcome Eric to our Board of Directors,” said Brian C. Thomas, PhD, CEO and founder of Metagenomi. “His tremendous track record in the pharmaceutical industry as well as his ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

The de-extinction company led by CEO Ben Lamm has raked in $435 million in funding since its launch. He believes it has ...

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious ...